Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion
Xiaohua Lu, Mohamed Elbadawi, Sebastian Blatt, Mohamed E.M. Saeed, Xiaolin Xiao, Xiao Ma, Edmond Fleischer, Peer W. Kämmerer, Thomas Efferth
Topics & Concepts
AngiogenesisMicroscale thermophoresisCancer researchIn vivoAngiogenesis inhibitorCancer cellSorafenibArtemisininKinase insert domain receptorPharmacologyVascular endothelial growth factorChemistryCancerBiologyBiochemistryVascular endothelial growth factor AVEGF receptorsImmunologyHepatocellular carcinomaBiotechnologyMalariaGeneticsPlasmodium falciparumAngiogenesis and VEGF in CancerCancer Mechanisms and TherapyMultiple Myeloma Research and Treatments